Related Experiment Video
Updated: Apr 18, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Identification of HNRNPK as regulator of hepatitis C virus particle production
Marion Poenisch1, Philippe Metz1, Hagen Blankenburg2
1Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
Insights
Heterogeneous nuclear ribonucleoprotein K (HNRNPK) suppresses Hepatitis C virus (HCV) particle production by limiting viral RNA incorporation into new virions. This study reveals a new role for HNRNPK in regulating viral replication cycles.
Area of Science:
- Virology
- Molecular Biology
- Hepatology
Background:
- Hepatitis C virus (HCV) causes chronic liver disease, impacting millions globally.
- Understanding host-pathogen interactions is crucial for developing antiviral strategies.
- Detailed mechanisms of HCV interaction with host cells remain incompletely understood.
Purpose of the Study:
- To identify host factors influencing the Hepatitis C virus life cycle.
- To elucidate the role of heterogeneous nuclear ribonucleoprotein K (HNRNPK) in HCV replication.
- To investigate the molecular mechanisms by which HNRNPK regulates HCV production.
Main Methods:
- Whole-virus RNA interference-based screening to identify host factors.
- Knock-down rescue experiments to map functional domains of HNRNPK.
- RNA-binding assays and mutational analysis to assess HNRNPK-HCV RNA interaction.
- Cellular localization studies using microscopy in HCV-infected cells.
Main Results:
- A comprehensive screen identified 40 host dependency and 16 host restriction factors for HCV.
- HNRNPK was identified as a novel suppressor of HCV particle production, independent of viral RNA replication.
- HNRNPK specifically interacts with HCV RNA, and this interaction is essential for its suppressive function.
- HNRNPK relocalizes to lipid droplets in infected cells, co-localizing with viral components.
Conclusions:
- HNRNPK plays a critical role in regulating the efficiency of Hepatitis C virus particle production.
- HNRNPK may limit HCV production by controlling viral RNA availability for virion assembly.
- This study uncovers a new function for HNRNPK as a regulator in the HCV replication cycle and potentially other viral systems.
Abstract:
Hepatitis C virus (HCV) is a major cause of chronic liver disease affecting around 130 million people worldwide. While great progress has been made to define the principle steps of the viral life cycle, detailed knowledge how HCV interacts with its host cells is still limited. To overcome this limitation we conducted a comprehensive whole-virus RNA interference-based screen and identified 40 host dependency and 16 host restriction factors involved in HCV entry/replication or assembly/release. Of these factors, heterogeneous nuclear ribonucleoprotein K (HNRNPK) was found to suppress HCV particle production without affecting viral RNA replication. This suppression of virus production was specific to HCV, independent from assembly competence and genotype, and not found with the related Dengue virus. By using a knock-down rescue approach we identified the domains within HNRNPK required for suppression of HCV particle production. Importantly, HNRNPK was found to interact specifically with HCV RNA and this interaction was impaired by mutations that also reduced the ability to suppress HCV particle production. Finally, we found that in HCV-infected cells, subcellular distribution of HNRNPK was altered; the protein was recruited to sites in close proximity of lipid droplets and colocalized with core protein as well as HCV plus-strand RNA, which was not the case with HNRNPK variants unable to suppress HCV virion formation. These results suggest that HNRNPK might determine efficiency of HCV particle production by limiting the availability of viral RNA for incorporation into virions. This study adds a new function to HNRNPK that acts as central hub in the replication cycle of multiple other viruses.
Related Concept Videos
Hepatitis
Regulation of Nuclear Protein Sorting
Inhibitors of Viral Protein Synthesis
Viruses with RNA Genomes

